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describes the highlights of the Tokyo International Consensus 
Meeting in 2006. Some important areas focused on at the 
meeting include proposals for internationally accepted diag-
nostic criteria and severity assessment for both clinical and 
research purposes.
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Introduction
More than 100 years have elapsed since Charcot’s triad 
was ﬁ  rst proposed as the characteristic ﬁ  ndings of acute 
cholangitis,1 and Murphy’s sign was proposed as a diag-
nostic method for acute cholecystitis.2 During this peri-
od, many new technologies have been developed for the 
management of acute biliary infections. Antimicrobial 
therapy, endoscopic techniques for both diagnosis and 
treatment, minimally invasive operations, including 
laparoscopic surgery and mini-laparotomy, and fast-
track surgery3 are good examples of such advances. De-
spite the great advances in medicine, acute cholangitis 
and acute cholecystitis are still great health problems in 
both developed and developing countries. According to 
Abstract
The Tokyo Guidelines formulate clinical guidance for health-
care providers regarding the diagnosis, severity assessment, 
and treatment of acute cholangitis and acute cholecystitis. The 
Guidelines were developed through a comprehensive litera-
ture search and selection of evidence. Recommendations were 
based on the strength and quality of evidence. Expert consen-
sus opinion was used to enhance or formulate important areas 
where data were insufﬁ  cient. A working group, composed of 
gastroenterologists and surgeons with expertise in biliary tract 
surgery, supplemented with physicians in critical care medi-
cine, epidemiology, and laboratory medicine, was selected to 
formulate draft guidelines. Several other groups (including 
members of the Japanese Society for Abdominal Emergency 
Medicine, the Japan Biliary Association, and the Japanese 
Society of Hepato-Biliary-Pancreatic Surgery) have reviewed 
and revised the draft guidelines. To build a global consensus 
on the management of acute biliary infection, an international 
expert panel, representing experts in this area, was estab-
lished. Between April 1 and 2, 2006, an International Consen-
sus Meeting on acute biliary infections was held in Tokyo. A 
consensus was determined based on best available scientiﬁ  c 
evidence and discussion by the panel of experts. This report 
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epidemiological studies, about 5%–15% of people in 
developed countries have gallstones,4–9  and annually, 
1% to 3% of these people develop severe gallstone 
diseases, including acute cholangitis and acute cholecys-
titis.10 Although mortality related to these diseases is 
relatively rare, they lay a heavy burden on the public, 
because gallstones are so common and hospitalization 
is expensive. According to Kim et al.,11 the total direct 
costs for gallbladder diseases per year in the United 
States are estimated to be $5.8 billion. Many clinical 
studies have been conducted to assess the risk of the 
disease, the accuracy of diagnostic techniques, and the 
effectiveness of the treatments. However, the accumu-
lation and integration of such scientiﬁ  c knowledge for 
application to clinical practice lags behind the progress 
achieved in medical and surgical technology.12 For ex-
ample, many studies have suggested that there are wide 
variations in the care of acute biliary infections in every 
part of the world.13,14 If there were “a best treatment”, 
such variation might imply low quality of care.
In order to develop the best possible practice patterns 
by integrating clinical experience with the best available 
research information, the Committee on the Develop-
ment of Guidelines for the Management of Acute Bili-
ary Infection (principal investigator, Tadahiro Takada) 
(hereafter, the Committee) prepared a draft of “Evi-
dence-based clinical practice guidelines for the manage-
ment of acute cholangitis and cholecystitis”. The major 
objectives in developing the guidelines were: (1) to 
propose standardized diagnostic criteria and severity 
assessment for both acute cholangitis and acute chole-
cystitis; and (2) to propose the best strategies for the 
management of acute biliary infections. The Committee 
selected a multidisciplinary Working Group composed 
of experts in hepatobiliary surgery, gastroenterology, 
intensive care, laboratory medicine, epidemiology, and 
pediatrics.
Through discussions within the Working Group 
and between the members of the scientiﬁ  c societies 
relevant to clinical practice in acute biliary infections, 
the draft was ﬁ  nalized. Subsequently, in April 2006, 
an international meeting was held in Tokyo to build 
global consensus on the management of acute biliary 
infection; the international consensus panel was com-
posed of leaders in hepatobiliary medicine from across 
the world. In this article, we describe the methodology 
and process of developing of the guidelines, and the 
basic principles and strategies we used to reach global 
consensus.
Need for standardized diagnostic criteria and 
severity assessment
In the Guidelines, we (the Working Group) propose 
uniform criteria for the diagnostic criteria and severity 
assessment of acute cholangitis and cholecystitis. In the 
process of developing the Guidelines, the Committee 
members considered that uniform diagnostic criteria for 
acute biliary infections were necessary for both research 
and clinical purposes. Because more than a dozen dif-
ferent local diagnostic criteria are now in use, compari-
son of treatment effectiveness between studies and 
comparisons of clinical outcomes across institutions are 
often difﬁ  cult. For example, although Charcot’s triad 
(abdominal pain, fever, and jaundice) has been histori-
cally used as the diagnostic criterion of acute cholangi-
tis, no more than 70% of patients with acute cholangitis 
have the triad.15,16 The reported mortality rates of acute 
cholangitis have a wide range (3.9%–65%), probably 
due to the lack of standardized criteria. Murphy’s sign 
has often been used in the diagnosis of acute cholecys-
titis. This sign is only useful when other physical ﬁ  ndings 
are equivocal, as in mild cholecystitis, and it has a sen-
sitivity and speciﬁ  city of only 65% and 87%.
Management of acute biliary infections according to 
severity grade is also critical, because the urgency of 
treatment and patient outcomes differ according to the 
severity of the disease. A literature review revealed that 
terminologies used to deﬁ  ne severe cases often failed to 
distinguish such cases from others. For example, Reyn-
olds’ pentad,17  which consists of Charcot’s triad plus 
“shock” and “decrease in level of consciousness”, has 
been used historically to deﬁ  ne severe acute cholangitis. 
The incidence of the pentad is extremely low, and is less 
than 10% even in severe cases.15 There is no doubt that 
better criteria, which enable physicians to provide ap-
propriate care according to the severity of the disease, 
are necessary.
Proposals for the diagnostic criteria were developed 
by beginning with existing deﬁ  nitions and concepts of 
acute biliary infections. The working group ﬁ  rst exam-
ined how historical writings and prestigious textbooks 
have deﬁ  ned acute cholangitis and cholecystitis, and 
tried to propose criteria to comply with these deﬁ  ni-
tions. We gave priority to the easy and early diagnosis 
of acute cholangitis by using noninvasive examinations. 
We also endeavored to incorporate the results of the 
latest clinical research in the diagnostic and severity 
assessment criteria.
By a systematic search through the literature and 
textbooks, the working group discussed the deﬁ  nitions 
of acute cholangitis and cholecystitis. The basic concepts 
of the criteria for acute cholangitis include: (1) Char-
cot’s triad as the deﬁ  nite criteria for the diagnosis of 
acute cholangitis, and (2) the presence of “biliary infec-M. Sekimoto et al.: Standardized diagnostic criteria for acute cholangitis and cholecystitis  13
tion” and “bile duct obstruction” proven by laboratory 
examinations and imaging. “Severe acute cholangitis” 
was deﬁ  ned as cholangitis with organ failure and/or sep-
sis. “Acute cholecystitis” was deﬁ  ned as the presenta-
tion of clinical signs such as epigastric pain, tenderness, 
muscle guarding, a palpable mass, Murphy’s sign, and 
inﬂ  ammatory signs. “Severe acute cholecystitis” was 
deﬁ  ned as acute cholecystitis with organ dysfunction.
Process of developing the Guidelines
We planned to use an evidence-based approach to 
develop our guidelines. We used established criteria 
and systematic methods for reviewing evidence of clini-
cal effectiveness. However, using only evidence-based 
data, we were unable to establish a useful set of guide-
lines.18 From the literature review, the Working Group 
found that, for some topics in the management of acute 
biliary infections, few studies could be classiﬁ  ed at high 
levels of evidence, and that treatment strategies for spe-
ciﬁ  c health conditions sometimes differed widely by re-
gion and country. There was a concern that such lack of 
evidence would not produce any recommendations that 
would be helpful to clinicians who encountered patients 
with acute biliary infections. As in other areas of medi-
cine, we recognized that, if the authors of the Tokyo 
Guidelines insisted upon strict adherence to an ap-
proach which accepted only studies rated at a high level 
of evidence in order to formulate guidelines, the vast 
majority of medical practice would be excluded from 
the practice guidelines. Therefore, to develop the Guide-
lines, we shifted our approach to one which combined 
the best of the literature studies with the best clinical 
opinion, based on a formal consensus approach. This 
strategy has the dual advantage of allowing the formula-
tion of the best guidelines possible at the present time, 
while pointing out areas in which studies are needed in 
order to formulate future guidelines based solely upon 
high levels of evidence.
Between April 1 and 2, 2006, an International Con-
sensus Meeting on Acute Biliary Infections was held in 
Tokyo, in which an expert panel consisting of 30 over-
seas panelists and 30 Japanese panelists tried to reach 
consensus on recommendations at a structured 2-day 
conference. The expert panel was provided with the 
draft of the guidelines prepared by the Working Group 
that reviewed the existing scientiﬁ  c evidence for a pro-
cedure, as well as providing a list of indications for per-
forming the procedure. In principle, the recommendations 
were based on the best available evidence. However, in 
the absence of high-quality evidence, expert consensus 
was integral to developing the Guidelines. The Guide-
lines are based on evidence, on discussion by the ex-
perts, and on consensus reached by voting. The panel 
recognized that speciﬁ  c patient care decisions may be 
at variance with these guidelines and that these deci-
sions are the prerogative of the patient and of the health 
professionals providing care.
The Guidelines are intended not only for specialists 
engaged in the diagnosis and treatment of acute biliary 
diseases but also for the general practitioner who has 
ﬁ  rst contact with these patients. The Guidelines were 
prepared to provide medical workers who play an active 
part at the front line with the best medical practice em-
ploying currently available data for the best outcome of 
the latest clinical research. The Guidelines consist of 
“clinical questions” that clinicians have in their daily 
medical practice, and responses to them. For a better 
understanding of the Guidelines, the sequences of diag-
nosis and treatment are explained with ﬂ  owcharts. It is 
our goal for the Guidelines to help users to provide best 
medical practice according to their specialty and capa-
bility, and thereby to improve the management of acute 
biliary infection.
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